EDAP TMS SA (EDAP) CFO discloses stock and option holdings on Form 3 filing
Rhea-AI Filing Summary
EDAP TMS SA filed an initial ownership report showing that Chief Financial Officer Kenneth S. Mobeck beneficially owns 56,610 shares of common stock as of 01/01/2026, held directly. This amount includes restricted stock units granted under the company’s 2025 RSU (Free Share) Plan, where each RSU represents the right to receive one share of EDAP common stock with vesting stretching from the second anniversary of the June 20, 2025 grant date through June 20, 2028.
He also directly holds stock options covering 375,000 shares exercisable until 12/15/2032 at $11.68 per share, options on 100,000 shares expiring 01/18/2034 at $6.22 per share, and options on 165,000 shares expiring 06/20/2035 at $1.74 per share. The options vest in stages over several years based on specified schedules tied to each grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes restricted stock units ("RSUs") granted pursuant to the 2025 RSU (Free Share) Plan of the issuer on June 20, 2025. Each RSU represents the right to receive one share of EDAP common stock, four-sixths of which will vest on the second anniversary of the date of grant and the remaining two-sixths will vest in two installments on December 20, 2027 and on June 20, 2028, respectively. The options, which were granted on December 15, 2022, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options. The option exercise price reflected was converted from 9.94 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750. The options, which were granted on January 18, 2024, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options. The option exercise price reflected was converted from 5.29 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750. One-sixth of the options become exercisable on December 20, 2025, which is the six-month anniversary of the date of grant, and with respect to the remaining five-sixths of the options, one-thirtieth become exercisable at the end of each month following the six-month anniversary of the date of grant. The option exercise price reflected was converted from 1.48 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.